Literature DB >> 25109669

The first knockin mouse model of episodic ataxia type 2.

Samuel J Rose1, Lisa H Kriener1, Ann K Heinzer2, Xueliang Fan1, Robert S Raike1, Arn M J M van den Maagdenberg3, Ellen J Hess4.   

Abstract

Episodic ataxia type 2 (EA2) is an autosomal dominant disorder associated with attacks of ataxia that are typically precipitated by stress, ethanol, caffeine or exercise. EA2 is caused by loss-of-function mutations in the CACNA1A gene, which encodes the α1A subunit of the CaV2.1 voltage-gated Ca(2+) channel. To better understand the pathomechanisms of this disorder in vivo, we created the first genetic animal model of EA2 by engineering a mouse line carrying the EA2-causing c.4486T>G (p.F1406C) missense mutation in the orthologous mouse Cacna1a gene. Mice homozygous for the mutated allele exhibit a ~70% reduction in CaV2.1 current density in Purkinje cells, though surprisingly do not exhibit an overt motor phenotype. Mice hemizygous for the knockin allele (EA2/- mice) did exhibit motor dysfunction measurable by rotarod and pole test. Studies using Cre-flox conditional genetics explored the role of cerebellar Purkinje cells or cerebellar granule cells in the poor motor performance of EA2/- mice and demonstrate that manipulation of either cell type alone did not cause poor motor performance. Thus, it is possible that subtle dysfunction arising from multiple cell types is necessary for the expression of certain ataxia syndromes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ataxia; CACNA1A; Cerebellar granule cell; Channelopathy; Cre; EA2; Episodic ataxia type 2; Knockin; Purkinje cell; Voltage-gated calcium channel

Mesh:

Substances:

Year:  2014        PMID: 25109669      PMCID: PMC4194266          DOI: 10.1016/j.expneurol.2014.08.001

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  60 in total

1.  KCa channels as therapeutic targets in episodic ataxia type-2.

Authors:  Karina Alviña; Kamran Khodakhah
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

2.  The therapeutic mode of action of 4-aminopyridine in cerebellar ataxia.

Authors:  Karina Alviña; Kamran Khodakhah
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

3.  Delayed postnatal loss of P/Q-type calcium channels recapitulates the absence epilepsy, dyskinesia, and ataxia phenotypes of genomic Cacna1a mutations.

Authors:  Melanie D Mark; Takashi Maejima; Denise Kuckelsberg; Jong W Yoo; Robert A Hyde; Viral Shah; Davina Gutierrez; Rosa L Moreno; Wolfgang Kruse; Jeffrey L Noebels; Stefan Herlitze
Journal:  J Neurosci       Date:  2011-03-16       Impact factor: 6.167

Review 4.  Episodic ataxias 1 and 2.

Authors:  Robert W Baloh
Journal:  Handb Clin Neurol       Date:  2012

Review 5.  Primary episodic ataxias: diagnosis, pathogenesis and treatment.

Authors:  J C Jen; T D Graves; E J Hess; M G Hanna; R C Griggs; R W Baloh
Journal:  Brain       Date:  2007-06-15       Impact factor: 13.501

6.  Paroxysmal dyskinesias in mice.

Authors:  Thomas L Shirley; Lekha M Rao; Ellen J Hess; H A Jinnah
Journal:  Mov Disord       Date:  2008-01-30       Impact factor: 10.338

7.  A destructive interaction mechanism accounts for dominant-negative effects of misfolded mutants of voltage-gated calcium channels.

Authors:  Alexandre Mezghrani; Arnaud Monteil; Katrin Watschinger; Martina J Sinnegger-Brauns; Christian Barrère; Emmanuel Bourinet; Joël Nargeot; Jörg Striessnig; Philippe Lory
Journal:  J Neurosci       Date:  2008-04-23       Impact factor: 6.167

8.  Dominant-negative effects of episodic ataxia type 2 mutations involve disruption of membrane trafficking of human P/Q-type Ca2+ channels.

Authors:  Chung-Jiuan Jeng; Min-Chen Sun; Yi-Wen Chen; Chih-Yung Tang
Journal:  J Cell Physiol       Date:  2008-02       Impact factor: 6.384

Review 9.  CaV2.1 channelopathies.

Authors:  Daniela Pietrobon
Journal:  Pflugers Arch       Date:  2010-03-04       Impact factor: 3.657

Review 10.  Clinical neurophysiology of the episodic ataxias: insights into ion channel dysfunction in vivo.

Authors:  Susan E Tomlinson; Michael G Hanna; Dimitri M Kullmann; S Veronica Tan; David Burke
Journal:  Clin Neurophysiol       Date:  2009-09-05       Impact factor: 3.708

View more
  8 in total

1.  Ubiquitin Ligase RNF138 Promotes Episodic Ataxia Type 2-Associated Aberrant Degradation of Human Cav2.1 (P/Q-Type) Calcium Channels.

Authors:  Ssu-Ju Fu; Chung-Jiuan Jeng; Chia-Hao Ma; Yi-Jheng Peng; Chi-Ming Lee; Ya-Ching Fang; Yi-Ching Lee; Sung-Chun Tang; Meng-Chun Hu; Chih-Yung Tang
Journal:  J Neurosci       Date:  2017-02-06       Impact factor: 6.167

2.  A new knock-in mouse model of l-DOPA-responsive dystonia.

Authors:  Samuel J Rose; Xin Y Yu; Ann K Heinzer; Porter Harrast; Xueliang Fan; Robert S Raike; Valerie B Thompson; Jean-Francois Pare; David Weinshenker; Yoland Smith; Hyder A Jinnah; Ellen J Hess
Journal:  Brain       Date:  2015-07-27       Impact factor: 13.501

3.  A Single Amino Acid Deletion (ΔF1502) in the S6 Segment of CaV2.1 Domain III Associated with Congenital Ataxia Increases Channel Activity and Promotes Ca2+ Influx.

Authors:  Maria Isabel Bahamonde; Selma Angèlica Serra; Oliver Drechsel; Rubayte Rahman; Anna Marcé-Grau; Marta Prieto; Stephan Ossowski; Alfons Macaya; José M Fernández-Fernández
Journal:  PLoS One       Date:  2015-12-30       Impact factor: 3.240

4.  Downregulation of Purkinje Cell Activity by Modulators of Small Conductance Calcium-Activated Potassium Channels In Rat Cerebellum.

Authors:  T V Karelina; Yu D Stepanenko; P A Abushik; D A Sibarov; S M Antonov
Journal:  Acta Naturae       Date:  2016 Oct-Dec       Impact factor: 1.845

Review 5.  Voltage-Gated Ca2+-Channel α1-Subunit de novo Missense Mutations: Gain or Loss of Function - Implications for Potential Therapies.

Authors:  Jörg Striessnig
Journal:  Front Synaptic Neurosci       Date:  2021-03-03

Review 6.  Calcium channelopathies and intellectual disability: a systematic review.

Authors:  Miriam Kessi; Baiyu Chen; Jing Peng; Fangling Yan; Lifen Yang; Fei Yin
Journal:  Orphanet J Rare Dis       Date:  2021-05-13       Impact factor: 4.123

7.  Mitochondrial Dysfunction may explain symptom variation in Phelan-McDermid Syndrome.

Authors:  Richard E Frye; Devin Cox; John Slattery; Marie Tippett; Stephen Kahler; Doreen Granpeesheh; Shirish Damle; Agustin Legido; Michael J Goldenthal
Journal:  Sci Rep       Date:  2016-01-29       Impact factor: 4.379

Review 8.  Overlaps, gaps, and complexities of mouse models of Developmental and Epileptic Encephalopathy.

Authors:  Wanqi Wang; Wayne N Frankel
Journal:  Neurobiol Dis       Date:  2020-12-07       Impact factor: 5.996

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.